DUBLIN–(BUSINESS WIRE)–The “Eye Allergy Therapeutics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Global Eye Allergy Therapeutics Market to Reach $3.9 Billion by 2027
Amid the COVID-19 crisis, the global market for Eye Allergy Therapeutics estimated at US$ 2.8 Billion in the year 2020, is projected to reach a revised size of US$ 3.9 Billion by 2027, growing at a CAGR of 4.8% over the analysis period 2020-2027.
Antihistamines, one of the segments analyzed in the report, is projected to record a 5.3% CAGR and reach US$ 1.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mast Cell Stabilizers segment is readjusted to a revised 4.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $765.1 Million, While China is Forecast to Grow at 7.9% CAGR
The Eye Allergy Therapeutics market in the U.S. is estimated at US$ 765.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$ 834.9 Million by the year 2027 trailing a CAGR of 7.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 3.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.
Corticosteroids Segment to Record 4.4% CAGR
In the global Corticosteroids segment, USA, Canada, Japan, China and Europe will drive the 4.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$ 381.6 Million in the year 2020 will reach a projected size of US$ 506.2 Million by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$ 530.8 Million by the year 2027, while Latin America will expand at a 4.7% CAGR through the analysis period.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Global Competitor Market Shares
- Eye Allergy Therapeutics Competitor Market Share Scenario Worldwide (in %): 2020E
- Global Competitor Market Shares by Segment
2. FOCUS ON SELECT PLAYERS (Total 43 Featured):
- Akorn Inc.
- Allergan Plc
- Allergy Therapeutics
- Bausch Health Companies Inc.
- Novartis AG
- Santen Pharmaceutical Co. Ltd.
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
- World 15-Year Perspective for Eye Allergy Therapeutics by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
- World 15-Year Perspective for Antihistamines by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
- World 15-Year Perspective for Mast Cell Stabilizers by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
- World 15-Year Perspective for Corticosteroids by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
- World 15-Year Perspective for Immunomodulators by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
- World 15-Year Perspective for Other Types by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
III. GEOGRAPHICAL MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 43
For more information about this report visit https://www.researchandmarkets.com/r/busec1
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900